Frequent expression of midkine gene in esophageal cancer suggests a potential usage of its promoter for suicide gene therapy

Jpn J Cancer Res. 1999 Apr;90(4):469-75. doi: 10.1111/j.1349-7006.1999.tb00771.x.

Abstract

We have examined the expression of midkine (MK), a neurotrophic factor with heparin-binding activity, in human esophageal cancer cells. Seven esophageal cell lines tested expressed the transcript and 8 out of 14 human esophageal tumor specimens were positively stained with anti-MK antibody, while surrounding normal esophageal tissues in these specimens were not stained. The 5'-flanking, 2.3 kb genomic region of the MK gene was shown to drive the transcription of a reporter gene in the esophageal cell lines in a cis acting manner. Forced expression in esophageal cancer cells of herpes simplex virus-thymidine kinase gene mediated by the flanking region of the MK gene conferred sensitivity to a prodrug, ganciclovir. The 5'-upstream region of the MK gene thus possesses putative promoter activity which can be used for suicide gene-based gene therapy for esophageal cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antiviral Agents / therapeutic use
  • Carrier Proteins / genetics*
  • Cytokines*
  • Esophageal Neoplasms / therapy*
  • Female
  • Ganciclovir / therapeutic use
  • Gene Expression Regulation, Neoplastic / physiology*
  • Gene Transfer Techniques
  • Genetic Therapy / methods*
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Midkine
  • Neoplasm Proteins / genetics*
  • Nerve Growth Factors / genetics*
  • Promoter Regions, Genetic
  • Tumor Cells, Cultured

Substances

  • Antiviral Agents
  • Carrier Proteins
  • Cytokines
  • Neoplasm Proteins
  • Nerve Growth Factors
  • Midkine
  • Ganciclovir